Indraprastha Medical Corporation Share Price Today (INDRAMEDCO)
TODAY IN ONE LINE
INDRAMEDCO slipped 0.4% on light volume, in line with Nifty's 0.3% move.
With a market cap of ₹3,443.24 Cr., it trades at a P/E of 19.06. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Indraprastha Medical Corporation flags
Key strengths and potential risks.
Green Flags
- ●High Capital EfficiencyROCE of 35.8% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 27.5%
- ●Healthy Operating MarginsOPM is structurally strong at 18.0%
- ●High Promoter HoldingPromoters hold 51.0% skin-in-the-game
- ●Steady Dividend YieldReliable 1.19% dividend yield
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Rising Receivables vs SalesReceivables grew 32.2% outpacing sales growth of 9.0%
What changed recently?
Recent events, corporate actions, and announcements.
Indraprastha Medical Corporation Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Indraprastha Medical Corporation Limited, framed against the sector median so the premium or discount is obvious at a glance.
Indraprastha Medical Corporation Limited trades at a P/E of 19.06× and P/B of 4.73×.
Valuation
Profitability
Growth
Financial Health
Indraprastha Medical Corporation Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Indraprastha Medical Corporation Limited — derived from the live tape, not yesterday's close.
Indraprastha Medical Corporation Limited last traded at ₹375.55 with an intraday range of ₹372.95–₹378.45 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹375.55| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 389.35 | +13.80 | +3.67% |
| R3 | 383.85 | +8.30 | +2.21% |
| R2 | 381.15 | +5.60 | +1.49% |
| R1 | 378.35 | +2.80 | +0.75% |
| PIVOT | 375.65 | 0.10 | 0.03% |
| CURRENT | 375.55 | — | — |
| S1 | 372.85 | -2.70 | -0.72% |
| S2 | 370.15 | -5.40 | -1.44% |
| S3 | 367.35 | -8.20 | -2.18% |
| S4 | 361.85 | -13.70 | -3.65% |
INDRAMEDCO is trading Below CPR, indicating Bearishness
CPR is Narrower, suggesting likely for trending moves
Day's range: ₹372.95–₹378.45
Trading Inside opening range
Indraprastha Medical Corporation Limited financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Indraprastha Medical Corporation Limited, switchable between annual and quarterly views, consolidated or standalone.
Indraprastha Medical Corporation Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹3,443.24 Cr. and reported EPS of ₹20.04.
Indraprastha Medical Corporation segment analysis: revenue and profit mix.
Disclosed business segments at Indraprastha Medical Corporation with their share of revenue and profit, switchable between consolidated and standalone reporting.
Indraprastha Medical Corporation discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Indraprastha Medical Corporation Limited.
Our AI distills the core fundamental drivers supporting Indraprastha Medical Corporation Limited, the risks that threaten it, and the exact valuation or growth triggers that should make you re-evaluate.
Indraprastha Medical Corporation Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
ROE 27.50% and ROCE 35.80% substantially exceed healthcare sector averages.
Debt-to-equity 0.0005x indicates minimal leverage and fortress-like balance sheet.
Operating margin 15.06% TTM surpasses peer median, demonstrating operational efficiency.
Promoter holding 51% ensures aligned governance and long-term strategic commitment.
Operating cash flow ₹93.51 Cr demonstrates robust earnings quality and liquidity generation.
Key Risks.
Latest quarterly EPS grew 1.7% YoY, indicating sluggish earnings momentum.
P/E 18.90x trades above sector median, suggesting moderate valuation premium.
Net cash flow -₹0.12 Cr in 2025 signals working capital pressure and liquidity tightness.
FII holdings declined sharply from 2.94% to 0.09%, reducing foreign investor conviction.
Dividend yield 1.19% offers modest income relative to peer alternatives.
Flip Conditions.
Trim if P/E re-rates above 25. The valuation cushion thins from there.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Exit if ROE slips below 23%. The operating engine is no longer compounding capital efficiently.
Income thesis breaks if the dividend is cut or yield falls below 0.59%.
Indraprastha Medical Corporation Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Indraprastha Medical Corporation Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Indraprastha Medical Corporation Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Indraprastha Medical Corporation Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Indraprastha Medical Corporation Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Indraprastha Medical Corporation Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Indraprastha Medical Corporation Limited stood at 59.4% of traded volume, against a 20-day average of 55.1%.
Indraprastha Medical Corporation announcements: results, concalls, ratings, M&A.
Filings Indraprastha Medical Corporation sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Indraprastha Medical Corporation files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 60 documents below.
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Indraprastha Medical Corporation Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Disclosure under SEBI Takeover Regulations
APOLLO HOSPITALS ENTERPRISE LIMITED has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board…
Analysts/Institutional Investor Meet/Con. Call Updates
Indraprastha Medical Corporation Limited has informed the Exchange about Schedule of meet
Credit Rating
Indraprastha Medical Corporation Limited has informed the Exchange about Credit Rating
Copy of Newspaper Publication
Indraprastha Medical Corporation Limited has informed the Exchange about Copy of Newspaper Publication
Investor decks & rating reports.
Indraprastha Medical Corporation dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Indraprastha Medical Corporation has declared, sequenced by announce and record date.
Indraprastha Medical Corporation corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Indraprastha Medical Corporation Limited: business, sector, key facts.
What Indraprastha Medical Corporation Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Indraprastha Medical Corporation Limited operates in the Hospital industry under the Healthcare sector, listed as NSE: INDRAMEDCO, BSE: 532150.
Indraprastha Medical Corporation Limited
Indraprastha Medical Corporation Limited (INDRAMEDCO) is a prominent healthcare provider in India, operating a multi-specialty hospital in New Delhi. Their business model centers around delivering a wide range of medical services under one roof, catering to diverse patient needs and offering comprehensive care.
The hospital's services span numerous medical specialties, reflecting a commitment to holistic patient care. These include core areas like general surgery (including laparoscopic and robotic procedures), cardiology, oncology, and orthopedics. They also offer specialized services in high-demand areas such as bariatric and metabolic surgery, bone marrow transplant, IVF (in-vitro fertilization), and transplant services in general. Further strengthening their comprehensive approach are offerings in areas like endocrinology, gastroenterology, neurology, and psychiatry.
Beyond surgical and specialist care, INDRAMEDCO provides extensive diagnostic and support services. These encompass laboratory services, radiology and radio diagnosis, and advanced imaging techniques like nuclear medicine. The hospital also has dedicated departments for anesthesiology, critical care, emergency medicine, and rehabilitation, ensuring complete patient management from diagnosis to recovery. Preventive health services and specialized care for geriatric patients (elder care) further enhance their service portfolio.
The breadth of services offered demonstrates INDRAMEDCO's strategy to be a one-stop healthcare destination. This minimizes the need for patients to seek care from multiple providers, improving efficiency and convenience. The incorporation of advanced technologies, such as robotic surgery and hyperbaric oxygen therapy, showcases a commitment to adopting modern medical practices and providing high-quality treatment.
Established in 1983, INDRAMEDCO has a long history of serving the healthcare needs of the New Delhi region. Their extensive service offering and commitment to various medical specialties position them as a significant player in the Indian healthcare landscape, focusing on providing comprehensive and advanced medical care.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Dr Agarwal's Health Care (AGARWALEYE) Share PricePeer
- Apollo Hospitals Enterprise (APOLLOHOSP) Share PricePeer
- Artemis Medicare Services (ARTEMISMED) Share PricePeer
- Aster DM Healthcare (ASTERDM) Share PricePeer
- Fortis Healthcare (FORTIS) Share PricePeer
- Other undervalued NSE stocksScreener
- Quality + Value Portfolio strategyStrategy
- Top quality scorecard stocksScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Indraprastha Medical Corporation Limited (INDRAMEDCO).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Indraprastha Medical Corporation Limited (INDRAMEDCO)?
The current share price of Indraprastha Medical Corporation Limited (INDRAMEDCO) is ₹375.55. Today, the stock has declined by ₹1.35 (0.36%), trading in a range of ₹372.95 to ₹378.45. The stock opened at ₹377 with a trading volume of 44,411 shares.
02Is Indraprastha Medical Corporation Limited stock a good investment for long-term?
Indraprastha Medical Corporation Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹3,443.24 crores, P/E ratio of 19.06, ROE of 27.50%, and ROCE of 35.80%. The dividend yield stands at 1.19%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Indraprastha Medical Corporation Limited stock?
The 52-week high price of Indraprastha Medical Corporation Limited (INDRAMEDCO) is ₹640.85, while the 52-week low is ₹342. Currently trading at ₹375.55, the stock is 11.2% away from its 52-week low and 41.4% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Indraprastha Medical Corporation Limited stock at the current price?
Whether to buy Indraprastha Medical Corporation Limited stock at ₹375.55 depends on multiple factors. The stock is currently trading with a P/E ratio of 19.06 and P/B ratio of 4.73. Today's performance shows a loss of 0.36%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Indraprastha Medical Corporation Limited and when is the next dividend?
Indraprastha Medical Corporation Limited offers a dividend yield of 1.19%, which means for every ₹100 invested at the current price of ₹375.55, you can expect to receive approximately ₹1.19 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Indraprastha Medical Corporation Limited?
Indraprastha Medical Corporation Limited's key financial metrics include: P/E Ratio: 19.06, P/B Ratio: 4.73, ROE: 27.50%, ROCE: 35.80%, Dividend Yield: 1.19%, EPS: ₹20.04, Book Value: ₹80.78, and Debt-to-Equity: 0.00. The company's market cap stands at ₹3,443.24 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Indraprastha Medical Corporation Limited stock performing today in the market?
Indraprastha Medical Corporation Limited stock opened at ₹377 and is currently trading at ₹375.55, showing a decline of ₹1.35 (0.36%). The intraday high is ₹378.45 and low is ₹372.95. The trading volume stands at 44,411 shares, indicating moderate market participation today.
08What is the P/E ratio of Indraprastha Medical Corporation Limited and what does it indicate?
Indraprastha Medical Corporation Limited has a Price-to-Earnings (P/E) ratio of 19.06, which means investors are willing to pay ₹19.06 for every ₹1 of earnings. With an EPS of ₹20.04, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Indraprastha Medical Corporation Limited (INDRAMEDCO) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.